Intra-fractional bladder motion and margins in adaptive radiotherapy for urinary bladder cancer

被引:30
作者
Gronborg, Caroline [1 ]
Vestergaard, Anne [1 ]
Hoyer, Morten [2 ]
Sohn, Matthias [3 ]
Pedersen, Erik M. [4 ]
Petersen, Jorgen B. [1 ]
Agerbaek, Mads [2 ]
Muren, Ludvig P. [1 ,2 ]
机构
[1] Aarhus Univ, Aarhus Univ Hosp, Dept Med Phys, Aarhus, Denmark
[2] Aarhus Univ, Dept Oncol, Aarhus Univ Hosp, Aarhus, Denmark
[3] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Dept Radiat Oncol, Munich, Germany
[4] Aarhus Univ, Dept Radiol, Aarhus Univ Hosp, Aarhus, Denmark
关键词
PHASE-II TRIAL; DOSE ACCUMULATION; RADIATION-THERAPY; PLAN SELECTION; ORGAN MOTION; IMPLEMENTATION; ERRORS; MRI;
D O I
10.3109/0284186X.2015.1062138
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The bladder is a tumour site well suited for adaptive radiotherapy (ART) due to large inter-fractional changes, but it also displays considerable intra-fractional motion. The aim of this study was to assess target coverage with a clinically applied method for plan selection ART and to estimate population-based and patient-specific intra-fractional margins, also relevant for a future re-optimisation strategy.Material and methods. Nine patients treated in a clinical phase II ART trial of daily plan selection for bladder cancer were included. In the library plans, 5 mm isotropic margins were added to account for intra-fractional changes. Pre-treatment and weekly repeat magnetic resonance imaging (MRI) series were acquired in which a full three-dimensional (3D) volume was scanned every second min for 10 min (a total of 366 scans in 61 series). Initially, the bladder clinical target volume (CTV) was delineated in all scans. The t = 0 min scan was then rigidly registered to the planning computed tomography (CT) and plan selections were simulated using the CTV_0 (at t = 0 min). To assess intra-fractional motion, coverage of the CTV_10 (at t = 10 min) was quantified using the applied PTV. Population-based margins were calculated using the van Herk margin recipe while patient-specific margins were calculated using a linear model.Results. For 49% of the cases, the CTV_10 extended more than 5 mm outside the CTV_0. However, in 58 of the 61 cases (97%) CTV_10 was covered by the selected PTV. Population-based margins of 14 mm Sup/Ant, 9 mm Post and 5 mm Inf/Lat were sufficient to cover the bladder. Using patient-specific margins, the overlap between PTV and bowel-cavity was reduced from 137 cm(3) with the plan selection strategy to 24 cm(3).Conclusion. In this phase II ART trial, 5 mm isotropic margin for intra-fractional motion was sufficient even though considerable intra-fractional motion was observed. In online re-optimised ART, population-based margin can be applied although patient-specific margins are preferable.
引用
收藏
页码:1461 / 1466
页数:6
相关论文
共 22 条
[1]   Inter- and intra-fractional bladder motion during radiotherapy for bladder cancer: A comparison of full and empty bladders [J].
Dees-Ribbers, Hermine M. ;
Betgen, Anja ;
Pos, Floris J. ;
Witteveen, Thelma ;
Remeijer, Peter ;
van Herk, Marcel .
RADIOTHERAPY AND ONCOLOGY, 2014, 113 (02) :254-259
[2]   The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART [J].
Foroudi, Farshad ;
Pham, Daniel ;
Rolfo, Aldo ;
Bressel, Mathias ;
Tang, Colin I. ;
Tan, Alex ;
Turner, Sandra ;
Hruby, George ;
Williams, Stephen ;
Hayne, Dickon ;
Lehman, Margot ;
Skala, Marketa ;
Jose, Chakiath C. ;
Gogna, Kumar ;
Kron, Tomas .
RADIOTHERAPY AND ONCOLOGY, 2014, 111 (02) :316-320
[3]   Intrafraction Bladder Motion in Radiation Therapy Estimated From Pretreatment and Posttreatment Volumetric Imaging [J].
Foroudi, Farshad ;
Pham, Daniel ;
Bressel, Mathias ;
Gill, Suki ;
Kron, Tomas .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (01) :77-82
[4]   Biology-guided adaptive radiotherapy (BiGART) - more than a vision? [J].
Grau, Cai ;
Hoyer, Morten ;
Alber, Markus ;
Overgaard, Jens ;
Lindegaard, Jacob Christian ;
Muren, Ludvig Paul .
ACTA ONCOLOGICA, 2013, 52 (07) :1243-1247
[5]   Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer [J].
Heukelom, Jolien ;
Hamming, Olga ;
Bartelink, Harry ;
Hoebers, Frank ;
Giralt, Jordi ;
Herlestam, Teresa ;
Verheij, Marcel ;
van den Brekel, Michiel ;
Vogel, Wouter ;
Slevin, Nick ;
Deutsch, Eric ;
Sonke, Jan-Jakob ;
Lambin, Philippe ;
Rasch, Coen .
BMC CANCER, 2013, 13
[6]   Tumor motion and deformation during external radiotherapy of bladder cancer [J].
Lotz, HT ;
Pos, FJ ;
Hulshof, MCCM ;
Van Herk, M ;
Lebesque, JV ;
Duppen, JC ;
Remeijer, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (05) :1551-1558
[7]   A model to predict bladder shapes from changes in bladder and rectal filling [J].
Lotz, HT ;
Remeijer, P ;
van Herk, M ;
Lebesque, JV ;
de Bois, JA ;
Zijp, LJ ;
Moonen, LM .
MEDICAL PHYSICS, 2004, 31 (06) :1415-1423
[8]   Assessing intra-fractional bladder motion using cine-MRI as initial methodology for Predictive Organ Localization (POLO) in radiotherapy for bladder cancer [J].
Mangar, Stephen A. ;
Scurr, Erica ;
Huddart, Robert A. ;
Sohaib, S. Aslam ;
Horwich, Alan ;
Dearnaley, David P. ;
Khoo, Vincent S. .
RADIOTHERAPY AND ONCOLOGY, 2007, 85 (02) :207-214
[9]   ASSESSMENT OF BLADDER MOTION FOR CLINICAL RADIOTHERAPY PRACTICE USING CINE-MAGNETIC RESONANCE IMAGING [J].
McBain, Catherine A. ;
Khoo, Vincent S. ;
Buckley, David L. ;
Sykes, Jonathan S. ;
Green, Melanie M. ;
Cowan, Richard A. ;
Hutchinson, Charles E. ;
Moore, Christopher J. ;
Price, Patricia M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03) :664-671
[10]   Clinical Implementation of Adaptive Hypofractionated Bladder Radiotherapy for Improvement in Normal Tissue Irradiation [J].
McDonald, F. ;
Lalondrelle, S. ;
Taylor, H. ;
Warren-Oseni, K. ;
Khoo, V. ;
McNair, H. A. ;
Harris, V. ;
Hafeez, S. ;
Hansen, V. N. ;
Thomas, K. ;
Jones, K. ;
Dearnaley, D. ;
Horwich, A. ;
Huddart, R. .
CLINICAL ONCOLOGY, 2013, 25 (09) :549-556